SecBot SecBot
SECBOTREPLAY Home › Report › NRXP

NRXP · NRx Pharmaceuticals priced an underwritten public offering of 5,714,286…

NRx Pharmaceuticals, Inc. · PRESS-RELEASE filed Jun 3, 2026 at 08:18 ET

At the news

BEARISHIMPACT 6/10

PRESS-RELEASE filed Jun 3, 2026 at 08:18 ET

NRx Pharmaceuticals priced an underwritten public offering of 5,714,286 shares at $3.50/share, with gross proceeds of ~$20.0M ($23.0M if underwriters fully exercise the 30-day option). The offering is dilutive (~11% of pre-offering shares) and proceeds are for working capital and general corporate purposes. The stock closed at $3.50 on June 3, 2026, indicating no premium/discount at pricing.

  • Pricing of 5,714,286 shares at $3.50 per share
  • Gross proceeds of approximately $20.0 million ($23.0 million if option exercised)
  • Underwriters granted 30-day option to purchase up to 857,142 additional shares
  • Offering expected to close June 4, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access